Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This escalation phase helps your body adjust to the compound and reduces the risk of side effects like nausea or digestive upset
This trial led the FDA to grant Wegovy a cardiovascular risk reduction indication in March 2024, making it the first anti-obesity medication with a heart-related label claim
Semaglutide Compounded Semaglutide promotes sustainable, personalized weight loss results
Frequently Asked Questions Does Medicare cover GLP-1 for weight loss only, or just diabetes
Individual response varies based on genetic factors, baseline metabolic health, and medication tolerance
Register or explore sponsorship opportunities for the 2026 GLP-1 Shopper Summit
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
